Evidence map›Paper›PMID 39005003›Full record

ArticleESC heart failure2024

Changes in waiting time, need for mechanical circulatory support and outcomes in paediatric heart transplant recipients.

Lisa-Maria Rosenthal, Annemarie Krauss, Oliver Miera, Friederike Danne, Fatima Lunze, Mi-Young Cho, Joachim Photiadis, Felix Berger, Katharina Schmitt

Abstract read
In one paragraph

Article in ESC heart failure, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Elevated filling pressures are associated with poor long-term graft survival after pediatric heart transplantation.Transplant international : official journal of the European Society for Organ Transplantation · 2026
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lisa-Maria RosenthalDepartment of Congenital Heart Disease-Pediatric Cardiology, Deutsches Herzzentrum der Charité, Berlin, Germany.ORCID 0000-0003-4083-1186
Annemarie KraussDepartment of Congenital Heart Disease-Pediatric Cardiology, Deutsches Herzzentrum der Charité, Berlin, Germany.
Oliver MieraDepartment of Congenital Heart Disease-Pediatric Cardiology, Deutsches Herzzentrum der Charité, Berlin, Germany.
Friederike DanneDepartment of Congenital Heart Disease-Pediatric Cardiology, Deutsches Herzzentrum der Charité, Berlin, Germany.
Fatima LunzeDepartment of Congenital Heart Disease-Pediatric Cardiology, Deutsches Herzzentrum der Charité, Berlin, Germany.
Mi-Young ChoDepartment of Congenital Heart Surgery, Deutsches Herzzentrum der Charité, Berlin, Germany.
Joachim PhotiadisDepartment of Congenital Heart Surgery, Deutsches Herzzentrum der Charité, Berlin, Germany.
Felix BergerDepartment of Congenital Heart Disease-Pediatric Cardiology, Deutsches Herzzentrum der Charité, Berlin, Germany.
Katharina SchmittDepartment of Congenital Heart Disease-Pediatric Cardiology, Deutsches Herzzentrum der Charité, Berlin, Germany.

Funding

Charité-Universitätsmedizin Berlin and Berlin Institute of Health at Charité (BIH)
6 · The paper itself

Abstract

aimsHeart transplantation is a well-established treatment for end-stage heart failure in paediatric patients, demonstrating excellent long-term outcomes.

methodsThis retrospective study analyses 35 years of data on 244 paediatric recipients (<18 years) at a single institution from 1986 to 2022. The analysis explores changes in diagnoses, survival, waiting times and mechanical circulatory support (MCS) over three decades (1991-2000, 2001-2010 and 2011-2020).

resultsSurvival outcomes significantly improved over the study period, with 1-year survival rates increasing from 79.3% (1991-2000) to 92.3% (2011-2020, P = 0.041). The median overall survival was 18.0 years, and median conditional survival to 1 year post-transplant was 20.9 years. Survival differences were noted among age groups, with infants under 1 year of age experiencing higher early mortality, and adolescents (aged 11-17 years) facing increased long-term risks, possibly linked to adult donor characteristics. Waiting times for heart transplantation increased, especially for younger age groups (0-5 and 6-10 years), reflecting the growing demand for donor organs. The use of MCS, including ventricular assist devices (VAD), surged, with 67% of recipients in the most recent decade receiving pre-transplant VAD support. Importantly, despite prolonged waiting times and increased VAD use, overall survival continued to be favourable.

conclusionsEarly and long-term results after paediatric heart transplantation have been continuously improving over the past decades. Despite an increased demand for donor organs and the growing reliance on VAD as bridge to transplantation, post-transplantation survival is not compromised.

Indexed as

Heart-Assist DevicesHeart FailureHeart TransplantationWaiting ListsAdolescentChildChild, PreschoolFemaleFollow-Up StudiesHumansInfantInfant, NewbornMaleRetrospective StudiesSurvival RateTime Factorsmechanical circulatory supportpaediatric heart transplantationventricular assist devices

Identifiers

PMID39005003
PMCPMC11631324

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.